Roche Group of Basel, Switzerland, has acquired Genentech of San Francisco. All of the latter company’s public shareholders will receive $95 per share. The Swiss company also signed an agreement to purchase 100 percent of innovatis AG of Bielefeld, Germany, for €15 million.